These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21711026)

  • 1. Free energy calculations on the two drug binding sites in the M2 proton channel.
    Gu RX; Liu LA; Wei DQ; Du JG; Liu L; Liu H
    J Am Chem Soc; 2011 Jul; 133(28):10817-25. PubMed ID: 21711026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.
    Gu RX; Liu LA; Wang YH; Xu Q; Wei DQ
    J Phys Chem B; 2013 May; 117(20):6042-51. PubMed ID: 23594107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does influenza virus a escape from amantadine?
    Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
    J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
    Du QS; Huang RB; Wang CH; Li XM; Chou KC
    J Theor Biol; 2009 Jul; 259(1):159-64. PubMed ID: 19285514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.
    Huang RB; Du QS; Wang CH; Chou KC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1243-7. PubMed ID: 18996090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
    Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
    Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.
    Wang JF; Chou KC
    Protein Eng Des Sel; 2010 Aug; 23(8):663-6. PubMed ID: 20571121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2.
    Gleed ML; Ioannidis H; Kolocouris A; Busath DD
    J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
    Wang JF; Wei DQ; Chou KC
    Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
    Du QS; Huang RB; Wang SQ; Chou KC
    PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
    J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers.
    Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M
    Nature; 2010 Feb; 463(7281):689-92. PubMed ID: 20130653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence determinants of a transmembrane proton channel: an inverse relationship between stability and function.
    Stouffer AL; Nanda V; Lear JD; DeGrado WF
    J Mol Biol; 2005 Mar; 347(1):169-79. PubMed ID: 15733926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of drug inhibition and drug resistance of influenza A M2 channel.
    Pielak RM; Schnell JR; Chou JJ
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7379-84. PubMed ID: 19383794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.
    Thomaston JL; Konstantinidi A; Liu L; Lambrinidis G; Tan J; Caffrey M; Wang J; Degrado WF; Kolocouris A
    Biochemistry; 2020 Feb; 59(4):627-634. PubMed ID: 31894969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the drug-resistant S31N influenza M2 proton channel.
    Thomaston JL; DeGrado WF
    Protein Sci; 2016 Aug; 25(8):1551-4. PubMed ID: 27082171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N.
    Deng C; Wang X; Wang T; Liu W; Yuan X; Huang Y; Cao S
    J Biomol Struct Dyn; 2024 Jul; 42(10):5253-5267. PubMed ID: 37424098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
    Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
    Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.